A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Transitional Cell Carcinoma of the Bladder
Interventions
DRUG

Amino levulinic Acid

The bladder cancer patients is required to swallow a chemical called Amino levulinic Acid, about 10mg/kg body weight. 5ml of blood and one urine samples will be taken before using Amino levulinic Acid. The patient must drink water then the urine will be collected after 4, 8 and 12 hours of taking ALA and the samples will be analyzed by photodynamic diagnostic procedure. ALA gets metabolized into certain types of porphyrins which selectively bind on to the tumor tissues (for a longer time than the normal tissues).

Trial Locations (1)

Unknown

King Khalid University Hospital, Riyadh

All Listed Sponsors
lead

Princess Al-Johara Al-Ibrahim Cancer Research Center

OTHER

NCT02101931 - A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine | Biotech Hunter | Biotech Hunter